Stock Price
0.62
Daily Change
-0.04 -6.06%
Monthly
-8.15%
Yearly
604.55%
Q2 Forecast
0.61

Starpharma Holdings reported AUD-4.85M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -20.3M 2.51M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025